Editorial comment on: Weekly docetaxel and prednisolone versus prednisolone alone in androgen-independent prostate cancer: a randomized phase II study.

Sorry, there's nothing here.

Cite this paper

@article{Bracarda2007EditorialCO, title={Editorial comment on: Weekly docetaxel and prednisolone versus prednisolone alone in androgen-independent prostate cancer: a randomized phase II study.}, author={Sergio Bracarda}, journal={European urology}, year={2007}, volume={52 6}, pages={1698-9} }